Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969790771> ?p ?o ?g. }
- W2969790771 endingPage "113616" @default.
- W2969790771 startingPage "113616" @default.
- W2969790771 abstract "We have demonstrated previously that the kinase inhibitors (KIs) lapatinib, pazopanib, regorafenib and sorafenib are potent inhibitors of UGT1A1 and UGTs 1A7-1A10. The present study characterised the effects of four additional drugs in this class, dabrafenib, ibrutinib, nintedanib and trametinib, on human UGT enzyme activities in vitro. Dabrafenib, ibrutinib, nintedanib and trametinib were potent inhibitors of human liver microsomal UGT1A1; Ki,u values ranged from 1.1 to 7.5 µM. Similarly, these KIs inhibited UGT 1A7, 1A8, 1A9 and 1A10, albeit less potently than UGT1A1. Despite the potent inhibition of UGT1A1, in vitro – in vivo extrapolation excluded the likelihood that dabrafenib, ibrutinib, nintedanib and trametinib would precipitate drug-drug interactions (DDIs) due to the low unbound plasma concentrations of these drugs observed in patients. The structures of dabrafenib, ibrutinib, lapatinib, nintedanib, pazopanib, regorafenib, trametinib and 22 other KIs overlaid well on that of sorafenib, a potent inhibitor of UGT1A1 and UGTs 1A7-1A10. Taken together, kinetic and computational modelling data suggest that all currently marketed KIs are likely to be potent inhibitors of UGT1A1, and are also likely to inhibit UGTs 1A7-1A10 to some extent due to the structural and chemical features shared in common by these drugs. By contrast, BIBF 1202, the major metabolite of nintedanib, did not appreciably inhibit human UGTs, due to the presence of a terminal electronegative group which appears to disfavor enzyme inhibition. Given the potent inhibition of several UGT enzymes, especially UGT1A1, by KIs, characterisation of the DDI potential of newly developed agents in this class is warranted." @default.
- W2969790771 created "2019-08-29" @default.
- W2969790771 creator A5006790855 @default.
- W2969790771 creator A5008901409 @default.
- W2969790771 creator A5034235905 @default.
- W2969790771 creator A5040080843 @default.
- W2969790771 creator A5071548469 @default.
- W2969790771 date "2019-11-01" @default.
- W2969790771 modified "2023-10-18" @default.
- W2969790771 title "Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202" @default.
- W2969790771 cites W1608710587 @default.
- W2969790771 cites W1608753926 @default.
- W2969790771 cites W1966851745 @default.
- W2969790771 cites W1975722213 @default.
- W2969790771 cites W1991853425 @default.
- W2969790771 cites W2001125416 @default.
- W2969790771 cites W2004292348 @default.
- W2969790771 cites W2016335393 @default.
- W2969790771 cites W2016623506 @default.
- W2969790771 cites W2061587734 @default.
- W2969790771 cites W2075966551 @default.
- W2969790771 cites W2083878214 @default.
- W2969790771 cites W2098429461 @default.
- W2969790771 cites W2098531214 @default.
- W2969790771 cites W2099617203 @default.
- W2969790771 cites W2100738068 @default.
- W2969790771 cites W2108230265 @default.
- W2969790771 cites W2116812374 @default.
- W2969790771 cites W2122481217 @default.
- W2969790771 cites W2128088654 @default.
- W2969790771 cites W2129969134 @default.
- W2969790771 cites W2137297158 @default.
- W2969790771 cites W2137442330 @default.
- W2969790771 cites W2140856191 @default.
- W2969790771 cites W2155066847 @default.
- W2969790771 cites W2157501385 @default.
- W2969790771 cites W2159146649 @default.
- W2969790771 cites W2166184616 @default.
- W2969790771 cites W2170030318 @default.
- W2969790771 cites W2180592540 @default.
- W2969790771 cites W2262767515 @default.
- W2969790771 cites W2508865467 @default.
- W2969790771 cites W2527403886 @default.
- W2969790771 cites W2567935285 @default.
- W2969790771 cites W2591615675 @default.
- W2969790771 cites W2607922282 @default.
- W2969790771 cites W2744246623 @default.
- W2969790771 cites W2752210999 @default.
- W2969790771 cites W2767226776 @default.
- W2969790771 cites W2784894383 @default.
- W2969790771 cites W2789759427 @default.
- W2969790771 cites W2887073112 @default.
- W2969790771 cites W2941718905 @default.
- W2969790771 cites W4236178060 @default.
- W2969790771 doi "https://doi.org/10.1016/j.bcp.2019.08.018" @default.
- W2969790771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31445021" @default.
- W2969790771 hasPublicationYear "2019" @default.
- W2969790771 type Work @default.
- W2969790771 sameAs 2969790771 @default.
- W2969790771 citedByCount "22" @default.
- W2969790771 countsByYear W29697907712020 @default.
- W2969790771 countsByYear W29697907712021 @default.
- W2969790771 countsByYear W29697907712022 @default.
- W2969790771 countsByYear W29697907712023 @default.
- W2969790771 crossrefType "journal-article" @default.
- W2969790771 hasAuthorship W2969790771A5006790855 @default.
- W2969790771 hasAuthorship W2969790771A5008901409 @default.
- W2969790771 hasAuthorship W2969790771A5034235905 @default.
- W2969790771 hasAuthorship W2969790771A5040080843 @default.
- W2969790771 hasAuthorship W2969790771A5071548469 @default.
- W2969790771 hasConcept C121608353 @default.
- W2969790771 hasConcept C126322002 @default.
- W2969790771 hasConcept C149151106 @default.
- W2969790771 hasConcept C184235292 @default.
- W2969790771 hasConcept C185592680 @default.
- W2969790771 hasConcept C2776131300 @default.
- W2969790771 hasConcept C2776248978 @default.
- W2969790771 hasConcept C2777329042 @default.
- W2969790771 hasConcept C2777472916 @default.
- W2969790771 hasConcept C2777477808 @default.
- W2969790771 hasConcept C2777658100 @default.
- W2969790771 hasConcept C2777938653 @default.
- W2969790771 hasConcept C2778439243 @default.
- W2969790771 hasConcept C2778461978 @default.
- W2969790771 hasConcept C2778472372 @default.
- W2969790771 hasConcept C2778830669 @default.
- W2969790771 hasConcept C2779490328 @default.
- W2969790771 hasConcept C2779786085 @default.
- W2969790771 hasConcept C2779878957 @default.
- W2969790771 hasConcept C2994587330 @default.
- W2969790771 hasConcept C502942594 @default.
- W2969790771 hasConcept C526805850 @default.
- W2969790771 hasConcept C530470458 @default.
- W2969790771 hasConcept C55493867 @default.
- W2969790771 hasConcept C57074206 @default.
- W2969790771 hasConcept C71924100 @default.
- W2969790771 hasConcept C98274493 @default.
- W2969790771 hasConceptScore W2969790771C121608353 @default.